<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Cardiovascular and Renal Drugs Advisory Committee; Amendment of Notice</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Cardiovascular and Renal Drugs Advisory Committee; Amendment of Notice</h1>
    <p class="timestamp">Published: 2015-03-18 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Cardiovascular and Renal Drugs Advisory Committee. This meeting was announced in the Federal Register of February 27, 2015 (80 FR 10700). The amendment is being made to reflect a change in the Agenda portion of the document. There are no other changes.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2015-06130</p>
    <p><strong>Publication Date:</strong> 2015-03-18</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2015/03/18/2015-06130/cardiovascular-and-renal-drugs-advisory-committee-amendment-of-notice">https://www.federalregister.gov/documents/2015/03/18/2015-06130/cardiovascular-and-renal-drugs-advisory-committee-amendment-of-notice</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2015-06130</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
